Business Description
RPG Life Sciences Ltd
ISIN : INE105J01010
Compare
Compare
Traded in other countries / regions
RPGLIFE.India IPO Date
2008-06-10Description
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.73 | |||||
| Interest Coverage | 221.16 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 14.56 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.6 | |||||
| 3-Year EBITDA Growth Rate | 24.1 | |||||
| 3-Year EPS without NRI Growth Rate | 27.6 | |||||
| 3-Year FCF Growth Rate | -20.4 | |||||
| 3-Year Book Growth Rate | 20.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.9 | |||||
| 9-Day RSI | 62.61 | |||||
| 14-Day RSI | 61.97 | |||||
| 6-1 Month Momentum % | 7.15 | |||||
| 12-1 Month Momentum % | 57.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.28 | |||||
| Quick Ratio | 1.5 | |||||
| Cash Ratio | 0.96 | |||||
| Days Inventory | 250.58 | |||||
| Days Sales Outstanding | 41.52 | |||||
| Days Payable | 172.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.99 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| Forward Dividend Yield % | 0.99 | |||||
| 5-Year Yield-on-Cost % | 0.99 | |||||
| Shareholder Yield % | 0.97 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.48 | |||||
| Operating Margin % | 19.56 | |||||
| Net Margin % | 15.26 | |||||
| FCF Margin % | 5.85 | |||||
| ROE % | 19.32 | |||||
| ROA % | 14.12 | |||||
| ROIC % | 24.42 | |||||
| ROC (Joel Greenblatt) % | 45.57 | |||||
| ROCE % | 25.46 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 40.62 | |||||
| PE Ratio without NRI | 40.62 | |||||
| Shiller PE Ratio | 74.39 | |||||
| Price-to-Owner-Earnings | 33.58 | |||||
| PEG Ratio | 1.36 | |||||
| PS Ratio | 6.2 | |||||
| PB Ratio | 7.11 | |||||
| Price-to-Tangible-Book | 7.68 | |||||
| Price-to-Free-Cash-Flow | 105.98 | |||||
| Price-to-Operating-Cash-Flow | 28.23 | |||||
| EV-to-EBIT | 28.69 | |||||
| EV-to-EBITDA | 25.05 | |||||
| EV-to-Revenue | 5.84 | |||||
| EV-to-FCF | 100.98 | |||||
| Price-to-Projected-FCF | 3.3 | |||||
| Price-to-Median-PS-Value | 3.39 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.69 | |||||
| Price-to-Graham-Number | 3.46 | |||||
| Price-to-Net-Current-Asset-Value | 16.64 | |||||
| Earnings Yield (Greenblatt) % | 3.49 | |||||
| FCF Yield % | 0.94 | |||||
| Forward Rate of Return (Yacktman) % | 21.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RPG Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 4,297 | ||
| EPS (TTM) (₹) | 39.65 | ||
| Beta | 0.63 | ||
| Volatility % | 34.67 | ||
| 14-Day RSI | 61.97 | ||
| 14-Day ATR (₹) | 57.395732 | ||
| 20-Day SMA (₹) | 1537.4 | ||
| 12-1 Month Momentum % | 57.44 | ||
| 52-Week Range (₹) | 907.2 - 1740 | ||
| Shares Outstanding (Mil) | 16.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RPG Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RPG Life Sciences Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
RPG Life Sciences Ltd Frequently Asked Questions
What is RPG Life Sciences Ltd(NSE:RPGLIFE)'s stock price today?
The current price of NSE:RPGLIFE is ₹1610.40. The 52 week high of NSE:RPGLIFE is ₹1740.00 and 52 week low is ₹907.20.
When is next earnings date of RPG Life Sciences Ltd(NSE:RPGLIFE)?
The next earnings date of RPG Life Sciences Ltd(NSE:RPGLIFE) is .
Does RPG Life Sciences Ltd(NSE:RPGLIFE) pay dividends? If so, how much?
The Dividend Yield %  of RPG Life Sciences Ltd(NSE:RPGLIFE) is 0.99% (As of Today), Highest Dividend Payout Ratio of RPG Life Sciences Ltd(NSE:RPGLIFE) was 0.62. The lowest was 0.23. And the median was 0.32. The  Forward Dividend Yield % of RPG Life Sciences Ltd(NSE:RPGLIFE) is 0.99%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers